459 related articles for article (PubMed ID: 33042267)
1. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice.
Ma ZG; Kong CY; Wu HM; Song P; Zhang X; Yuan YP; Deng W; Tang QZ
Theranostics; 2020; 10(24):11013-11025. PubMed ID: 33042267
[No Abstract] [Full Text] [Related]
2. Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.
McLaughlin D; Zhao Y; O'Neill KM; Edgar KS; Dunne PD; Kearney AM; Grieve DJ; McDermott BJ
Br J Pharmacol; 2017 Nov; 174(21):3677-3695. PubMed ID: 28261787
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
4. C1qTNF-related protein 1 attenuates doxorubicin-induced cardiac injury via activation of AKT.
Chen H; Gao L; Huang Z; Liu Y; Guo S; Xing J; Meng Z; Liang C; Li Y; Yao R; Li L; Zhang Y; Gu H; Liu Y
Life Sci; 2018 Aug; 207():492-498. PubMed ID: 29964055
[TBL] [Abstract][Full Text] [Related]
5. GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress.
Wang Y; Lei T; Yuan J; Wu Y; Shen X; Gao J; Feng W; Lu Z
Redox Biol; 2018 Jul; 17():25-34. PubMed ID: 29660505
[TBL] [Abstract][Full Text] [Related]
6. Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis.
Zhang WB; Lai X; Guo XF
Oxid Med Cell Longev; 2021; 2021():8860883. PubMed ID: 33574984
[TBL] [Abstract][Full Text] [Related]
7. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis.
Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J
Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748
[TBL] [Abstract][Full Text] [Related]
8. MD-1 Deficiency Accelerates Myocardial Inflammation and Apoptosis in Doxorubicin-Induced Cardiotoxicity by Activating the TLR4/MAPKs/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Zhang YJ; Huang H; Liu Y; Kong B; Wang G
Med Sci Monit; 2019 Oct; 25():7898-7907. PubMed ID: 31636246
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity.
Liu Y; Duan C; Liu W; Chen X; Wang Y; Liu X; Yue J; Yang J; Zhou X
Arch Toxicol; 2019 Nov; 93(11):3261-3276. PubMed ID: 31570982
[TBL] [Abstract][Full Text] [Related]
10. miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice.
Li J; Wan W; Chen T; Tong S; Jiang X; Liu W
Biomed Res Int; 2019; 2019():1528278. PubMed ID: 31355248
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy.
Zhang QL; Yang JJ; Zhang HS
Biomed Pharmacother; 2019 Jan; 109():71-83. PubMed ID: 30396094
[TBL] [Abstract][Full Text] [Related]
12. Endurance Exercise Attenuates Doxorubicin-induced Cardiotoxicity.
Lee Y; Kwon I; Jang Y; Cosio-Lima L; Barrington P
Med Sci Sports Exerc; 2020 Jan; 52(1):25-36. PubMed ID: 31318716
[TBL] [Abstract][Full Text] [Related]
13. Mitigation of doxorubicin-induced cardiotoxicity by dichloroacetate: potential roles of restoration of PGC-1α/SIRT3 signaling and suppression of oxidative stress and apoptosis.
Saleh MF; Elsayad ME; Goda AE
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6573-6584. PubMed ID: 34787860
[TBL] [Abstract][Full Text] [Related]
14. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats.
Wan Y; He B; Zhu D; Wang L; Huang R; Zhu J; Wang C; Gao F
Arch Biochem Biophys; 2021 Nov; 712():109050. PubMed ID: 34610336
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
17. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of valsartan administration on doxorubicin‑induced myocardial injury in rats and the role of oxidative stress and NOX2/NOX4 signaling.
Cheng D; Chen L; Tu W; Wang H; Wang Q; Meng L; Li Z; Yu Q
Mol Med Rep; 2020 Nov; 22(5):4151-4162. PubMed ID: 33000246
[TBL] [Abstract][Full Text] [Related]
19. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-143 Increases Oxidative Stress and Myocardial Cell Apoptosis in a Mouse Model of Doxorubicin-Induced Cardiac Toxicity.
Li XQ; Liu YK; Yi J; Dong JS; Zhang PP; Wan L; Li K
Med Sci Monit; 2020 Mar; 26():e920394. PubMed ID: 32170053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
